论文信息 - Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD) - 字舞流文

Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)

F. Saad | H. Scher | D. George | E. Yu | K. Fizazi | E. Efstathiou | P. Lara | K. Chi | W. Kelly | G. Mason | S. Sandhu | J. Simon | J. Summa | M. Smith | D. Ricci | E. Zhu | Shinta Cheng | J. Freedman